← Terbutaline Sulphate 1.25mg+Ammonium Chloride 60mg+Sodium Citrate 25mg/5mL

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Terbutaline Sulphate 1.25mg+Ammonium Chloride 60mg+Sodium Citrate 25mg/5mL

Beta-2 adrenergic agonist (bronchodilator)

Prepared 25 Sep 2026

What it is used for

Cough associated with bronchospasm in children. Clinical selection for Terbutaline Sulphate 1.25mg+Ammonium Chloride 60mg+Sodium Citrate 25mg/5mL should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Beta-2 adrenergic agonist (bronchodilator). Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Paradoxical bronchospasm. Hypokalaemia with high dose/nebs especially with steroids/diuretics/xanthines. CV disease: tachycardia/arrhythmia risk. Thyrotoxicosis caution.

Possible side effects

[From component Terbutaline sulphate] Tachycardia, skeletal muscle cramp, palpitation, headaches, severe emotional disturbances, resistance after prolonged use, acidosis, GI disturbances, hypokaleamia, sweat

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage